FOCAL CORTICAL DYSPLASIA

Clinical trials for FOCAL CORTICAL DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

Sign up with your email to follow new studies for FOCAL CORTICAL DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1 Terminated 1

New drug trial offers hope for untreatable seizure disorders

Disease control Not yet recruiting

This early-stage study is testing whether an oral drug called SVG103 is safe and tolerable for adults with three rare brain conditions that cause severe, hard-to-control seizures. About 15 participants will take the drug for up to 9 months while researchers monitor for side effec…

Matched conditions: FOCAL CORTICAL DYSPLASIA

Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

FOCAL CORTICAL DYSPLASIA

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

New drug trial offers hope for untreatable seizure disorders